Literature DB >> 30973732

Chiral Brønsted Acid-Catalyzed Metal-Free Asymmetric Direct Reductive Amination Using 1-Hydrosilatrane.

Vladislav Skrypai1, Sami E Varjosaari1,2, Fawwaz Azam3, Thomas M Gilbert1, Marc J Adler1,3.   

Abstract

The asymmetric direct reductive amination of prochiral ketones with aryl amines using 1-hydrosilatrane with a chiral Brønsted acid catalyst is reported. This is the first known example of chiral Brønsted acid-catalyzed asymmetric reductive amination using a silane as the hydride source. The reaction features a highly practical reducing reagent and proceeds efficiently at room temperature without a specialized reaction setup or equipment to exclude air or moisture. This method provides high conversion and enantiomeric excess up to 84% of the desired chiral secondary amines with minimal side products.

Entities:  

Year:  2019        PMID: 30973732     DOI: 10.1021/acs.joc.8b03073

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Multifunctional biocatalyst for conjugate reduction and reductive amination.

Authors:  Thomas W Thorpe; James R Marshall; Vanessa Harawa; Rebecca E Ruscoe; Anibal Cuetos; James D Finnigan; Antonio Angelastro; Rachel S Heath; Fabio Parmeggiani; Simon J Charnock; Roger M Howard; Rajesh Kumar; David S B Daniels; Gideon Grogan; Nicholas J Turner
Journal:  Nature       Date:  2022-04-06       Impact factor: 49.962

2.  GPhos Ligand Enables Production of Chiral N-Arylamines in a Telescoped Transaminase-Buchwald-Hartwig Amination Cascade in the Presence of Excess Amine Donor.

Authors:  Christian M Heckmann; Francesca Paradisi
Journal:  Chemistry       Date:  2021-10-08       Impact factor: 5.020

Review 3.  Chiral Phosphoric Acids as Versatile Tools for Organocatalytic Asymmetric Transfer Hydrogenations.

Authors:  Ádám Márk Pálvölgyi; Fabian Scharinger; Michael Schnürch; Katharina Bica-Schröder
Journal:  European J Org Chem       Date:  2021-10-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.